Navigation Links
Cylex Announces Significant Expansions and Reassignments of Personnel
Date:8/21/2008

Changes reflect increased focus on customer care and support

COLUMBIA, Md., Aug. 21 /PRNewswire/ -- Cylex(TM) is a global life sciences company that develops and manufactures research and in vitro diagnostic products based on its patented technology. Cylex is seeing continuing growth of its first marketed product, the ImmuKnow(R) assay for detection of cell-mediated immunity, and the Company believes that this product and the Company itself have still greater potential.

"The ability to fully support the needs of our customers is critical to the development of this company as a provider of diagnostic tests focused on the immune system," said Mr. Brad Stewart, the president of Cylex. "We have therefore made a series of key appointments designed primarily to address customer needs, and I am pleased to be able to announce these today."

-- Sharlene P. Blum has come to Cylex in the new position of Director, Customer Care. She had most recently held institutional and patient quality and service management positions with Quest Diagnostics. Ms. Blum is a results-oriented operations leader with over 20 years of experience in laboratory services operations management. She has also been awarded a Six Sigma Black Belt in project management.

-- Genesis E. Cautivar has joined the Company as a Laboratory Account Manager in the Customer Care group. He was previously a technical field specialist with Siemens Medical Solutions, where he focused on products used in the hematology marketplace.

-- Linyi Zhang has joined Cylex as Manager, Clinical Affairs. In this position she will focus on clinical trials of Cylex's current and development-stage products. She has over 20 years experience in biomedical research, assay development, product development, and clinical study in both academia and industry. Most recently, she was a clinical trials specialist with the National Institutes of Health. Prior to that she held various positions at Human Genome Sciences.

In addition, Cylex has appointed four new Business Development Managers, who will have regional field responsibilities for current and target customers in specific areas of the USA:

-- Hilary A. Comfort has previously held account management and sales positions with several well-known pharmaceutical and biotechnology companies, most recently including UCB Pharma and Astellas.

-- William T. Futch has come to the company from Zimmer Dental, where he was a territory manager, after additional prior field experience with Pfizer.

-- Greg Nabors brings over 15 years of field sales experience with leading pharmaceutical companies, including Aventis, Knoll Pharmaceutical and Wyeth-Ayerst Laboratories.

-- Eric G. Gann has been with Cylex since 2005 as a Laboratory Liaison and Laboratory Account Manager in the Customer Care group, and will be taking on this new role in business development.

About ImmuKnow(R)

ImmuKnow is the immune cell function assay cleared by the FDA to detect cell-mediated immunity (CMI) in adult patient populations undergoing immunosuppressive therapy for organ transplantation by measuring the concentration of adenosine triphosphate (ATP) released from CD4 cells following cell stimulation.

The ImmuKnow test is a qualitative assay and does not directly quantify the level of immunosuppression. Results of ImmuKnow assays should be used in conjunction with clinical presentation, medical history, and other clinical indicators when assessing the immune status of any individual patient.

About Cylex, Inc.

Cylex(TM) is a privately held global life sciences company that is the leader in the development and manufacture of in vitro diagnostic products intended to illuminate immunity. The Company's patented technology provides an innovative platform allowing clinical researchers to simply and reproducibly measure immune cell function for the development of new diagnostics, biomarkers, and companion assays. The Company is based in Columbia, MD, USA.


'/>"/>
SOURCE Cylex(TM)
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Multiple Independent Studies Report on Use of Cylexs Immune Cell Function Assay in Postoperative Monitoring of Kidney, Liver, and Heart Transplant Recipients
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... , ... Dr. Charles A. Ditta attained his Doctor of Medical Dentistry Degree ... 1986, where he graduated in the top ten percentile of his class. Dr. Ditta ... He has been a member in good standing for thirty years in the American ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... on patients with cancer, has added Cancer and Careers to its ... more timely content on continuing successful careers while fighting cancer. , As partners, ...
(Date:5/30/2016)... ... May 30, 2016 , ... ... inside of FCPX," said Christina Austin - CEO of Pixel Film Studios. ... within Final Cut Pro X. Choose from abstract transitions to more simple wipes ...
(Date:5/30/2016)... Texas (PRWEB) , ... May 30, 2016 , ... Another ... 7 am in Plano, located at 3960 Legacy Drive, Plano, TX and is open ... Plano Chamber of Commerce followed by a medical open house. The Jasper High School ...
(Date:5/29/2016)... Viejo, CA (PRWEB) , ... May 29, 2016 , ... ... Volume 3 let's the user control the style of their project," said Christina Austin ... set of 30 self-animating web-themed intros created exclusively for use in Final Cut Pro ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... -- , Isansys  Lifecare, a new generation digital ... wireless patient monitoring platform, as it ships more systems to ... , Scotland and Norway ... system, launched earlier this year, is now being used in ... This new technology significantly enhances the user experience and ...
(Date:5/30/2016)... 2016 According to a ... Market by Type (Stability, Raw Materials, Method Validation, ... (Pharmaceutical Companies, Medical Device Companies) - Global Forecast ... healthy growth during the last decade and is ... between 2016 and 2021 to reach USD 4.13 ...
(Date:5/30/2016)... , May 30, 2016 Eye expert ... of premature babies to seek an eye examination ... condition     Moorfields Eye Hospital Dubai, ... London , has identified premature babies as a ... because of their particular vulnerability to retinopathy of prematurity (ROP). ROP ...
Breaking Medicine Technology: